rupaller 10 mg tabletki
farmak international sp. z o.o. - rupatadini fumaras - tabletki - 10 mg
rupagen 10 mg tabletki
mylan s.a.s. - rupatadinum - tabletki - 10 mg
adrimax 30 mg/5 ml syrop
zakłady farmaceutyczne polpharma s.a. - levodropropizinum - syrop - 30 mg/5 ml
bilargena 20 mg tabletki
sandoz gmbh - bilastyna - tabletki - 20 mg
campto 20 mg/ml koncentrat do sporządzania roztworu do wlewów dożylnych
pfizer europe ma eeig - irinotecani hydrochloridum - koncentrat do sporządzania roztworu do wlewów dożylnych - 20 mg/ml
campto 100 mg/5 ml koncentrat do sporządzania roztworu do wlewów dożylnych
pfizer europe ma eeig - irinotecani hydrochloridum - koncentrat do sporządzania roztworu do wlewów dożylnych - 100 mg/5 ml
cinacalcet sandoz 60 mg tabletki powlekane
sandoz gmbh - cinacalcetum - tabletki powlekane - 60 mg
cinacalcet sandoz 90 mg tabletki powlekane
sandoz gmbh - cinacalcetum - tabletki powlekane - 90 mg
cinacalcet sandoz 30 mg tabletki powlekane
sandoz gmbh - cinacalcetum - tabletki powlekane - 30 mg
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - inne leki na układ nerwowy - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.